Tag: Lupin

Stocks that will see action today: January 19, 2024

Wipro Ltd has signed a definitive agreement to subscribe for a 14 per cent equity share in Huoban Energy 11,

Drug maker Lupin on Sunday said it has received approval from the US health regulator to market a generic

The board of Grasim Industries has approved ₹4,000-crore rights issue. The issue price has been fixed at ₹1,812 a rights

Tata Motors said that it has received a no-objection certificate from the National Stock Exchange and BSE for the conversion

Lupin Atlantis Holdings, a wholly-owned subsidiary of Lupin, has signed an Asset Purchase Agreement with French pharmaceutical company Sanofi.

Princeton-based Sun Pharmaceutical Industries Inc, a unit of the company, is recalling the affected lot that was produced at the

Global pharma major Lupin on Thursday announced the launch of Vilfuro-G, the world’s first fixed-dose triple combination drug (FDC) for

Cipla has received a Warning Letter dated November, 17 (Sunday) from United States Food and Drug Administration (USFDA) for the

Both companies have collaborated for the marketing of RaniFilesadmin.coumab in select territories of Jordan, Saudi Arabia, among others Pharma

Lupin Ltd and Amman Pharmaceuticals Industries (Amman Pharma) have entered into an exclusive licensing and supply agreement for the biosimilar